These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29361126)

  • 1. Changes in co-morbidity pattern in patients starting renal replacement therapy in Europe-data from the ERA-EDTA Registry.
    Ceretta ML; Noordzij M; Luxardo R; De Meester J; Abad Diez JM; Finne P; Heaf JG; Couchoud C; Kramar R; Collart F; Cases A; Palsson R; Reisæter AV; Rydell H; Massy ZA; Jager KJ; Kramer A
    Nephrol Dial Transplant; 2018 Oct; 33(10):1794-1804. PubMed ID: 29361126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of co-morbidity in different European RRT populations and its effect on access to renal transplantation.
    Stel VS; van Dijk PC; van Manen JG; Dekker FW; Ansell D; Conte F; Kramar R; Leivestad T; Vela E; Briggs JD; Jager KJ
    Nephrol Dial Transplant; 2005 Dec; 20(12):2803-11. PubMed ID: 16188902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.
    Hruskova Z; Pippias M; Stel VS; Abad-Díez JM; Benítez Sánchez M; Caskey FJ; Collart F; De Meester J; Finne P; Heaf JG; Magaz A; Palsson R; Reisæter AV; Salama AD; Segelmark M; Traynor JP; Massy ZA; Jager KJ; Tesar V
    Am J Kidney Dis; 2019 Feb; 73(2):184-193. PubMed ID: 30122544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in renal registries between the Balkans and Western Europe.
    Stojceva-Taneva O; Selim GJ; Zafirovska K; Polenakovic M
    Prilozi; 2006 Dec; 27(2):37-47. PubMed ID: 17211290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifetime risk of renal replacement therapy in Europe: a population-based study using data from the ERA-EDTA Registry.
    van den Brand JAJG; Pippias M; Stel VS; Caskey FJ; Collart F; Finne P; Heaf J; Jais JP; Kramar R; Massy ZA; De Meester J; Traynor JP; Reisæter AV; Wetzels JFM; Jager KJ
    Nephrol Dial Transplant; 2017 Feb; 32(2):348-355. PubMed ID: 28031344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UK Renal Registry 16th annual report: chapter 5 comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2011 to 2012.
    Rao A; Steenkamp R; Caskey F
    Nephron Clin Pract; 2013; 125(1-4):99-110. PubMed ID: 24662169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chapter 4 Comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2009 to 2010.
    Shaw C; Webb L; Casula A; Tomson CR
    Nephron Clin Pract; 2012; 120 Suppl 1():c81-91. PubMed ID: 22964575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal replacement therapy for rare diseases affecting the kidney: an analysis of the ERA-EDTA Registry.
    Wühl E; van Stralen KJ; Wanner C; Ariceta G; Heaf JG; Bjerre AK; Palsson R; Duneau G; Hoitsma AJ; Ravani P; Schaefer F; Jager KJ
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv1-8. PubMed ID: 25165174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report on management of renale failure in Europe, XXVI, 1995. Rare diseases in renal replacement therapy in the ERA-EDTA Registry.
    Tsakiris D; Simpson HK; Jones EH; Briggs JD; Elinder CG; Mendel S; Piccoli G; dos Santos JP; Tognoni G; Vanrenterghem Y; Valderrabano F
    Nephrol Dial Transplant; 1996; 11 Suppl 7():4-20. PubMed ID: 9067983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006.
    Kramer A; Stel V; Zoccali C; Heaf J; Ansell D; Grönhagen-Riska C; Leivestad T; Simpson K; Pálsson R; Postorino M; Jager K;
    Nephrol Dial Transplant; 2009 Dec; 24(12):3557-66. PubMed ID: 19820003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry.
    Pippias M; Jager KJ; Kramer A; Leivestad T; Sánchez MB; Caskey FJ; Collart F; Couchoud C; Dekker FW; Finne P; Fouque D; Heaf JG; Hemmelder MH; Kramar R; De Meester J; Noordzij M; Palsson R; Pascual J; Zurriaga O; Wanner C; Stel VS
    Nephrol Dial Transplant; 2016 May; 31(5):831-41. PubMed ID: 26361801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UK Renal Registry 13th Annual Report (December 2010): Chapter 4: comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2008 to 2009.
    Webb L; Gilg J; Feest T; Fogarty D
    Nephron Clin Pract; 2011; 119 Suppl 2():c85-96. PubMed ID: 21894042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study.
    Tsakiris DJ; Stel VS; Finne P; Fraser E; Heaf J; de Meester J; Schmaldienst S; Dekker F; Verrina E; Jager KJ
    Nephrol Dial Transplant; 2010 Apr; 25(4):1200-6. PubMed ID: 20037169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of comorbidities on survival in patients >80 years of age at onset of renal replacement therapy: data from the ERA-EDTA Registry.
    Helve J; Kramer A; Abad Diez JM; Aresté-Fosalba N; Arici M; Cases A; Collart F; Heaf J; De Meester J; Nordio M; Palsson R; Pobes A; Rydell H; Reisæter AV; Massy ZA; Jager KJ; Finne P
    Nephrol Dial Transplant; 2021 Mar; 36(4):688-694. PubMed ID: 33537775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demographics of paediatric renal replacement therapy in Europe: a report of the ESPN/ERA-EDTA registry.
    Chesnaye N; Bonthuis M; Schaefer F; Groothoff JW; Verrina E; Heaf JG; Jankauskiene A; Lukosiene V; Molchanova EA; Mota C; Peco-Antić A; Ratsch IM; Bjerre A; Roussinov DL; Sukalo A; Topaloglu R; Van Hoeck K; Zagozdzon I; Jager KJ; Van Stralen KJ;
    Pediatr Nephrol; 2014 Dec; 29(12):2403-10. PubMed ID: 25039018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External Validation of a risk stratification model to assist shared decision making for patients starting renal replacement therapy.
    Peeters P; Van Biesen W; Veys N; Lemahieu W; De Moor B; De Meester J
    BMC Nephrol; 2016 Apr; 17():41. PubMed ID: 27055653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UK Renal Registry 11th Annual Report (December 2008): Chapter 6 Comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland: national and centre-specific analyses.
    Udayaraj U; Tomson CR; Gilg J; Ansell D; Fogarty D
    Nephron Clin Pract; 2009; 111 Suppl 1():c97-111. PubMed ID: 19542707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deaths within 90 days from starting renal replacement therapy in the ERA-EDTA Registry between 1990 and 1992.
    Tsakiris D; Jones EH; Briggs JD; Elinder CG; Mehls O; Mendel S; Piccoli G; Rigden SP; Pintos dos Santos J; Simpson K; Vanrenterghem Y
    Nephrol Dial Transplant; 1999 Oct; 14(10):2343-50. PubMed ID: 10528656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidities in UK patients at the start of renal replacement therapy (chapter 6).
    Tomson C; Udayaraj U; Gilg J; Ansell D
    Nephrol Dial Transplant; 2007 Aug; 22 Suppl 7():vii58-68. PubMed ID: 17724052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UK Renal Registry 16th annual report: chapter 1 UK renal replacement therapy incidence in 2012: national and centre-specific analyses.
    Gilg J; Rao A; Fogarty D
    Nephron Clin Pract; 2013; 125(1-4):1-27. PubMed ID: 24662165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.